HALO vs VFC · P/E 15, rev $857.7M vs P/E 26, rev $9.61B
Halozyme Therapeutics Inc (HALO) versus VF Corporation (VFC) — a side-by-side from cached financials, not a winner call.
Halozyme Therapeutics Inc (HALO) is a biotechnology company listed on US.
VF Corporation (VFC) is a apparel manufacturing company listed on NYSE.
Latest reported HALO revenue for 2026-06-30 was $857.7M. Net income was $380.0M. HALO currently screens at market cap $7.10B and trailing P/E 15.3.
Latest reported VFC revenue for 2026-03-28 was $9.61B. Net income was $254.9M. Revenue was up 1.1% from 2025-03-29 to 2026-03-28. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
HALO currently screens at market cap $7.10B and trailing P/E 15.3. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
Not investment advice. Open the HALO and VFC stock pages for the full models.
Not investment advice.